ASX lunch update: ANZ & Macquarie lower, Estia Health higher

Australia and New Zealand Banking Group (ASX:ANZ), Estia Health Ltd (ASX:EHE), and Macquarie Group Ltd (ASX:MQG) shares have been making moves on the ASX 200 on Friday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Friday the S&P/ASX 200 index has followed the lead of U.S. markets and dropped lower. At the time of writing the benchmark index is down 0.15% to 6,653.8 points.

Here's what has been happening on the market today:

a woman

Big four tumble again.         

The big four banks are all trading notably lower on Friday and are weighing on the market. The worst performer in the group is the Australia and New Zealand Banking Group (ASX: ANZ) share price with a decline of 1.5%. Investors have responded negatively to its decision to declare an 80 cents per share final dividend franked to just 70%.

Macquarie half year result.

The Macquarie Group Ltd (ASX: MQG) share price is down 2% at lunch following the release of its half year results. This morning the investment bank delivered a solid 11% increase in half year profits. However, I suspect investors are disappointed that management only retained its full year guidance. This is for a full year result slightly down on FY 2019.

Orica results.

The Orica Ltd (ASX: ORI) share price has edged higher after releasing its full year results. The chemicals company reported a NPAT before individually significant items of $372 million. This was a 15% increase on the prior corresponding period. Looking ahead, management advised that the outlook for FY 2020 and beyond is positive.

Best and worst performers.

The best performer on the ASX 200 index at lunch is the Estia Health Ltd (ASX: EHE) share price with a 4% gain. Investors appear to believe the Royal Commission interim report into aged care wasn't as bad as it could have been for Estia. Going the other way is the Pro Medicus Limited (ASX: PME) share price with a 5.5% decline. Investors have been selling its shares since one of its rivals won a major contract in Western Australia last month.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. The Motley Fool Australia has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Testing again

Read more »

Share Market News

Aaron Test 2

Read more »

Share Market News

Aaron Test

Read more »

Share Market News

JP Test

Read more »

Share Market News

JP Test

Read more »

Portrait of Discovery Fund portfolio managers Mark Devcich and Chris Bainbridge
Share Market News

Test

Portfolio managers Mark Devcich (left) and Chris Bainbridge. Image source: Discovery Fund test test

Read more »

a man in a hoodie grins slyly as he sits with his hands poised on a keyboard. He is superimposed with a graphic image of a computer screen asking for a password, suggesting he is a hacker.
Share Market News

Another ASX 200 company has been hit with a cyber incident. Here's what we know

Hackers have breached the systems of this ASX 200 company.

Read more »

a woman
Broker Notes

5 ASX 200 shares that inflation can't touch: expert

Regardless of whether you're a bull or a bear, cost pressures are a factor when buying stocks at the moment.

Read more »